Inspiratory help then sham ventilation
DeviceThe Inspiratory Pressure Support is used to increase the intensity and the duration of training session. For the sham ventilation, the device deliver a non effective quantity of oxygen.
NCT Number: NCT02506504
In patients with severe Chronic Obstructive Pulmonary Disease (COPD), exercise tolerance is severely impaired due to a ventilatory limitation, levelling off the intensity of exercise. This reduces the physiological benefit of pulmonary rehabilitation. In these patients, it is then proposed to add an Inspiratory Pressure Support (IPS) in order to increase the intensity and the duration of every training session. In a preliminary study, the investigators showed that IPS applied during an exhaustive cycling exercise allowed to prevent the onset of post-exercise quadriceps fatigue evaluated by the endurance time to isotonic quadriceps contractions (TlimQ).
The aim of this study is to determine the relationship between the prevention of post-exercise fatigue (TlimQ) and the change in training load (intensity x time x number of sessions) during a pulmonary rehabilitation programme. At the beginning of the training programme, 25 patients will be evaluated for TlimQ after a cycling exercise (70% maximal workload) with and without IPS in random order. The training load was then monitored at every exercise session of the programme.
Looking for future studies?
Notify Me18 year–80 year
All sexes
Interventional
Not applicable
CHU de Clermont-Ferrand, Clermont-Ferrand, France
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The Inspiratory Pressure Support is used to increase the intensity and the duration of training session. For the sham ventilation, the device deliver a non effective quantity of oxygen.
The Inspiratory Pressure Support is used to increase the intensity and the duration of training session. For the sham ventilation, the device deliver a non effective quantity of oxygen.
Time frame: Visit 24 (week 8)
At the beginning of the programme, we evaluate the influence of IPS on TlimQ (visits 2 and 3). After the training period, we repeated the same evaluations (visits 23 and 24). Then, we will compare this difference before and after the training period, and we will seek for a relation with the training load.
Time frame: Visit 3 (week 1)
We compare the endurance time to isotonic quadriceps contractions after a cycling exercice until exhaustion with and without IPS, at the beginning of the training period.
Time frame: Visit 24 (week 8)
we will compare the difference in endurance to exercise with IPS and the difference in endurance to isotonic quadriceps contractions
Time frame: Visit 24 (week 8)
we will seek for a relationship between the changes in the endurance time to cycling exercise without or with IPS and the variation in endurance to isotonic quadriceps contractions following cycling exercise
Time frame: Visit 24 (week 8)
Time frame: Visit 24 (week 8)
Centre Hospitalier Universitaire de Saint Etienne
Other
Prevention of Post-exercise Muscle Fatigue Using a Non Invasive Ventilation and Effect on Exercise Training in Severe Patients With COPD. QUADRIVEND Study
Acronym: QUADRIVEND
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05595733
Chronic Disease, Disease Attributes
Taipei, Taiwan
View Trial DetailsNCT02290535
Lung Diseases, Lung Diseases, Obstructive
Aachen, North Rhine-Westphalia, Germany
View Trial DetailsNCT02073708
Inflammation, Lung Diseases
Skien, Telemark, Norway
View Trial DetailsNCT02889029
Lung Diseases, Lung Diseases, Obstructive
Toulouse, CHU de Toulouse, France
View Trial Details